{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T22:15:04Z","timestamp":1787523304250,"version":"build-2736575974"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFC2507900"],"award-info":[{"award-number":["2023YFC2507900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11882-025-01227-4","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T05:09:49Z","timestamp":1760764189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Microneedles in Allergy Immunotherapy: the Present and Future"],"prefix":"10.1007","volume":"25","author":[{"given":"Yangxue","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxiu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongfei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,18]]},"reference":[{"key":"1227_CR1","doi-asserted-by":"publisher","first-page":"e12130","DOI":"10.1002\/clt2.12130","volume":"12","author":"M Savour\u00e9","year":"2022","unstructured":"Savour\u00e9 M, Bousquet J, Jaakkola JJK, Jaakkola MS, Jacquemin B, Nadif R. Worldwide prevalence of rhinitis in adults: A review of definitions and Temporal evolution. Clin Transl Allergy. 2022;12:e12130. https:\/\/doi.org\/10.1002\/clt2.12130.","journal-title":"Clin Transl Allergy"},{"key":"1227_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","volume":"396","author":"SM Langan","year":"2020","unstructured":"Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396:345\u201360. https:\/\/doi.org\/10.1016\/S0140-6736(20)31286-1.","journal-title":"Lancet"},{"key":"1227_CR3","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.jaip.2020.02.010","volume":"8","author":"SH Sicherer","year":"2020","unstructured":"Sicherer SH, Warren CM, Dant C, Gupta RS, Nadeau KC. Food allergy from infancy through adulthood. J Allergy Clin Immunol Pract. 2020;8:1854\u201364. https:\/\/doi.org\/10.1016\/j.jaip.2020.02.010.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1227_CR4","doi-asserted-by":"publisher","unstructured":"Shin YH, Hwang J, Kwon R, Lee SW, Kim MS et al. GBD 2019 Allergic Disorders Collaborators,. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. Allergy. 2023;78:2232\u201354. https:\/\/doi.org\/10.1111\/all.15807","DOI":"10.1111\/all.15807"},{"key":"1227_CR5","doi-asserted-by":"publisher","unstructured":"Yin W, Xiaoli Z, Wenjin D, Lin Y, Xiaofei Y, Qing J et al. Sensitization profiles of aeroallergens among allergic rhinitis patients in China: A 13-year multicenter retrospective study. Allergy. John Wiley & Sons, Ltd; 2024;79:1329\u201332. https:\/\/doi.org\/10.1111\/all.15784","DOI":"10.1111\/all.15784"},{"key":"1227_CR6","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","volume":"5","author":"PJ Turner","year":"2017","unstructured":"Turner PJ, Jerschow E, Umasunthar T, Lin R, Campbell DE, Boyle RJ. Fatal anaphylaxis: mortality rate and risk factors. J Allergy Clin Immunol Pract. 2017;5:1169\u201378. https:\/\/doi.org\/10.1016\/j.jaip.2017.06.031.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1227_CR7","doi-asserted-by":"publisher","unstructured":"Li L, Chen H, Huang N, Li W, Yang Y, Ma D et al. Anaphylaxis in outpatients: A 5-year retrospective study on incidence and clinical characteristics at a university hospital in Wuhan, China. https:\/\/doi.org\/10.1111\/all.16152","DOI":"10.1111\/all.16152"},{"key":"1227_CR8","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jaci.2023.07.009","volume":"152","author":"GW Canonica","year":"2023","unstructured":"Canonica GW, Varricchi G, Paoletti G, Heffler E, Virchow JC. Advancing precision medicine in asthma: evolution of treatment outcomes. J Allergy Clin Immunol. 2023;152:835\u201340. https:\/\/doi.org\/10.1016\/j.jaci.2023.07.009.","journal-title":"J Allergy Clin Immunol"},{"key":"1227_CR9","doi-asserted-by":"publisher","unstructured":"Ef K, van Rjj N. IgE versus IgG and iga: differential roles of allergen-specific antibodies in sensitization, tolerization, and treatment of allergies. Immunol Rev. 2024;328. https:\/\/doi.org\/10.1111\/imr.13386.","DOI":"10.1111\/imr.13386"},{"key":"1227_CR10","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jaip.2023.10.018","volume":"12","author":"JA Dantzer","year":"2024","unstructured":"Dantzer JA, Kim EH. New approaches to food allergy immunotherapy. J Allergy Clin Immunol Pract. 2024;12:546\u201352. https:\/\/doi.org\/10.1016\/j.jaip.2023.10.018.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1227_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41577-022-00786-1","volume":"23","author":"SR Durham","year":"2023","unstructured":"Durham SR, Shamji MH. Allergen immunotherapy: past, present and future. Nat Rev Immunol Nat Publishing Group. 2023;23:317\u201328. https:\/\/doi.org\/10.1038\/s41577-022-00786-1.","journal-title":"Nat Rev Immunol Nat Publishing Group"},{"key":"1227_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/pai.13189","volume":"31","author":"MA-L Ca","year":"2020","unstructured":"Ca MA-L, C AMA. EAACI allergen immunotherapy user\u2019s guide. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2020;31:25. https:\/\/doi.org\/10.1111\/pai.13189.","journal-title":"Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol"},{"key":"1227_CR13","doi-asserted-by":"publisher","unstructured":"J M, K L, R H, B B, V C. House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control-A RWE study. Allergy. 2024;79. https:\/\/doi.org\/10.1111\/all.16052.","DOI":"10.1111\/all.16052"},{"key":"1227_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/alr.21382","author":"R Am","year":"2014","unstructured":"Am R, Sk W. Subcutaneous immunotherapy. Int Forum Allergy Rhinol. 2014. https:\/\/doi.org\/10.1002\/alr.21382. 4 Suppl 2.","journal-title":"Int Forum Allergy Rhinol"},{"key":"1227_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11882-015-0586-1","volume":"16","author":"C Incorvaia","year":"2016","unstructured":"Incorvaia C, Mauro M, Leo G, Ridolo E. Adherence to Sublingual immunotherapy. Curr Allergy Asthma Rep. 2016;16:12. https:\/\/doi.org\/10.1007\/s11882-015-0586-1.","journal-title":"Curr Allergy Asthma Rep"},{"key":"1227_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/pai.13622","volume":"33","author":"M De Filippo","year":"2022","unstructured":"De Filippo M, Votto M, Caminiti L, Panasiti I, Carella F, De Castro G, et al. Safety of allergen-specific immunotherapy in children. Pediatr Allergy Immunol. 2022;33:27\u201330. https:\/\/doi.org\/10.1111\/pai.13622.","journal-title":"Pediatr Allergy Immunol"},{"key":"1227_CR17","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.immuni.2011.12.003","volume":"35","author":"P Di Meglio","year":"2011","unstructured":"Di Meglio P, Perera GK, Nestle FO. The multitasking organ: recent insights into skin immune function. Immun Elsevier. 2011;35:857\u201369. https:\/\/doi.org\/10.1016\/j.immuni.2011.12.003.","journal-title":"Immun Elsevier"},{"key":"1227_CR18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nri2622","volume":"9","author":"FO Nestle","year":"2009","unstructured":"Nestle FO, Di Meglio P, Qin J-Z, Nickoloff BJ. Skin immune sentinels in health and disease. Nat Rev Immunol Nat Publishing Group. 2009;9:679\u201391. https:\/\/doi.org\/10.1038\/nri2622.","journal-title":"Nat Rev Immunol Nat Publishing Group"},{"key":"1227_CR19","doi-asserted-by":"publisher","first-page":"1238022","DOI":"10.3389\/fimmu.2023.1238022","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang Z, Wu L, Wang W. Innovative delivery systems for epicutaneous immunotherapy. Front Immunol. 2023;14:1238022. https:\/\/doi.org\/10.3389\/fimmu.2023.1238022.","journal-title":"Front Immunol"},{"key":"1227_CR20","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nbt.1504","volume":"26","author":"MR Prausnitz","year":"2008","unstructured":"Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26:1261\u20138. https:\/\/doi.org\/10.1038\/nbt.1504.","journal-title":"Nat Biotechnol"},{"key":"1227_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2018.03.010","volume":"127","author":"Z Zhao","year":"2018","unstructured":"Zhao Z, Ukidve A, Dasgupta A, Mitragotri S. Transdermal immunomodulation: Principles, advances and perspectives. Adv Drug Deliv Rev. 2018;127:3\u201319. https:\/\/doi.org\/10.1016\/j.addr.2018.03.010.","journal-title":"Adv Drug Deliv Rev"},{"key":"1227_CR22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12967-020-02466-x","volume":"18","author":"F Marcucci","year":"2020","unstructured":"Marcucci F, Isidori C, Argentiero A, Neglia C, Esposito S. Therapeutic perspectives in food allergy. J Transl Med. 2020;18:302. https:\/\/doi.org\/10.1186\/s12967-020-02466-x.","journal-title":"J Transl Med"},{"key":"1227_CR23","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1111\/all.14220","volume":"75","author":"EH Kim","year":"2020","unstructured":"Kim EH, Burks AW. Food allergy immunotherapy: oral immunotherapy and epicutaneous immunotherapy. Allergy. 2020;75:1337\u201346. https:\/\/doi.org\/10.1111\/all.14220.","journal-title":"Allergy"},{"key":"1227_CR24","doi-asserted-by":"publisher","unstructured":"\u00a0Z G, T S, W Z, H F, J Y, Z G, et al. Microneedle-Mediated Cell Therapy. Adv Sci Weinh Baden-Wurtt Ger. 2024;11. https:\/\/doi.org\/10.1002\/advs.202304124.","DOI":"10.1002\/advs.202304124"},{"key":"1227_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.actbio.2020.12.004","volume":"121","author":"D Yang","year":"2021","unstructured":"Yang D, Chen M, Sun Y, Jin Y, Lu C, Pan X, et al. Microneedle-mediated transdermal drug delivery for treating diverse skin diseases. Acta Biomater. 2021;121:119\u201333. https:\/\/doi.org\/10.1016\/j.actbio.2020.12.004.","journal-title":"Acta Biomater"},{"key":"1227_CR26","doi-asserted-by":"publisher","first-page":"119673","DOI":"10.1016\/j.ijpharm.2020.119673","volume":"587","author":"AL Ahmed Saeed","year":"2020","unstructured":"Ahmed Saeed AL-, Mahmood S, Hamed Almurisi S, Reddy Venugopal J, Rebhi Hilles A, Azmana M, et al. Current trends in polymer microneedle for transdermal drug delivery. Int J Pharm. 2020;587:119673. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119673.","journal-title":"Int J Pharm"},{"key":"1227_CR27","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/jamadermatol.2017.0849","volume":"153","author":"TA Petukhova","year":"2017","unstructured":"Petukhova TA, Hassoun LA, Foolad N, Barath M, Sivamani RK. Effect of expedited Microneedle-Assisted photodynamic therapy for field treatment of actinic keratoses: A randomized clinical trial. JAMA Dermatol. 2017;153:637\u201343. https:\/\/doi.org\/10.1001\/jamadermatol.2017.0849.","journal-title":"JAMA Dermatol"},{"key":"1227_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ejpb.2023.01.024","volume":"185","author":"YT He","year":"2023","unstructured":"He YT, Hao YY, Yu RX, Zhang C, Chen BZ, Cui Y, et al. Hydroquinone cream-based polymer microneedle roller for the combined treatment of large-area Chloasma. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV. 2023;185:5\u201312. https:\/\/doi.org\/10.1016\/j.ejpb.2023.01.024.","journal-title":"Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV"},{"key":"1227_CR29","doi-asserted-by":"publisher","first-page":"32578","DOI":"10.1021\/acsnano.4c09527","volume":"18","author":"Y Cheng","year":"2024","unstructured":"Cheng Y, Zhang X, Wu X, Ding Y, Zhu L, Pan J, et al. Multifunctional microneedle patches for perivascular gene delivery and treatment of vascular intimal hyperplasia. ACS Nano. 2024;18:32578\u201388. https:\/\/doi.org\/10.1021\/acsnano.4c09527.","journal-title":"ACS Nano"},{"key":"1227_CR30","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1039\/d1tb00512j","volume":"9","author":"X Li","year":"2021","unstructured":"Li X, Xu Q, Wang J, Zhang P, Wang Y, Ji J. A gene-coated microneedle patch based on industrialized ultrasonic spraying technology with a polycation vector to improve antitumor efficacy. J Mater Chem B. 2021;9:5528\u201336. https:\/\/doi.org\/10.1039\/d1tb00512j.","journal-title":"J Mater Chem B"},{"key":"1227_CR31","doi-asserted-by":"publisher","first-page":"43588","DOI":"10.1021\/acsami.9b15668","volume":"11","author":"H Du","year":"2019","unstructured":"Du H, Liu P, Zhu J, Lan J, Li Y, Zhang L, et al. Hyaluronic Acid-Based dissolving microneedle patch loaded with methotrexate for improved treatment of psoriasis. ACS Appl Mater Interfaces. 2019;11:43588\u201398. https:\/\/doi.org\/10.1021\/acsami.9b15668.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1227_CR32","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1039\/c9tb00912d","volume":"8","author":"J Mao","year":"2020","unstructured":"Mao J, Wang H, Xie Y, Fu Y, Li Y, Liu P, et al. Transdermal delivery of Rapamycin with poor water-solubility by dissolving polymeric microneedles for anti-angiogenesis. J Mater Chem B. 2020;8:928\u201334. https:\/\/doi.org\/10.1039\/c9tb00912d.","journal-title":"J Mater Chem B"},{"key":"1227_CR33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jconrel.2022.05.045","volume":"348","author":"Z Sartawi","year":"2022","unstructured":"Sartawi Z, Blackshields C, Faisal W. Dissolving microneedles: applications and growing therapeutic potential. J Controlled Release. 2022;348:186\u2013205. https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.045.","journal-title":"J Controlled Release"},{"key":"1227_CR34","doi-asserted-by":"publisher","first-page":"e2202591","DOI":"10.1002\/advs.202202591","volume":"9","author":"P Liu","year":"2022","unstructured":"Liu P, Fu Y, Wei F, Ma T, Ren J, Xie Z, et al. Microneedle patches with O2 propellant for deeply and fast delivering photosensitizers: towards improved photodynamic therapy. Adv Sci Weinh Baden-Wurtt Ger. 2022;9:e2202591. https:\/\/doi.org\/10.1002\/advs.202202591.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"1227_CR35","doi-asserted-by":"publisher","unstructured":"C O, R S, F T, D W, A B, Y H, et al. Hollow silicon microneedles, fabricated using combined wet and dry etching techniques, for transdermal delivery and diagnostics. Int J Pharm. 2023;637. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122888.","DOI":"10.1016\/j.ijpharm.2023.122888"},{"key":"1227_CR36","doi-asserted-by":"publisher","unstructured":"F Q, R G, Y L, J Z. Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment. Theranostics. 2022;12. https:\/\/doi.org\/10.7150\/thno.69999.","DOI":"10.7150\/thno.69999"},{"key":"1227_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jconrel.2020.12.019","volume":"330","author":"H Amani","year":"2021","unstructured":"Amani H, Shahbazi M-A, D\u2019Amico C, Fontana F, Abbaszadeh S, Santos HA. Microneedles for painless transdermal immunotherapeutic applications. J Controlled Release. 2021;330:185\u2013217. https:\/\/doi.org\/10.1016\/j.jconrel.2020.12.019.","journal-title":"J Controlled Release"},{"key":"1227_CR38","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.apsb.2023.05.009","volume":"13","author":"J He","year":"2023","unstructured":"He J, Zhang Y, Yu X, Xu C. Wearable patches for transdermal drug delivery. Acta Pharm Sin B. 2023;13:2298\u2013309. https:\/\/doi.org\/10.1016\/j.apsb.2023.05.009.","journal-title":"Acta Pharm Sin B"},{"key":"1227_CR39","doi-asserted-by":"publisher","first-page":"e1884","DOI":"10.1002\/wnan.1884","volume":"15","author":"AJ Guillot","year":"2023","unstructured":"Guillot AJ, Mart\u00ednez-Navarrete M, Zinchuk-Mironova V, Melero A. Microneedle-assisted transdermal delivery of nanoparticles: recent insights and prospects. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023;15:e1884. https:\/\/doi.org\/10.1002\/wnan.1884.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"1227_CR40","doi-asserted-by":"publisher","first-page":"115315","DOI":"10.1016\/j.addr.2024.115315","volume":"209","author":"SA Shah","year":"2024","unstructured":"Shah SA, Oakes RS, Jewell CM. Advancing immunotherapy using biomaterials to control tissue, cellular, and molecular level immune signaling in skin. Adv Drug Deliv Rev. 2024;209:115315. https:\/\/doi.org\/10.1016\/j.addr.2024.115315.","journal-title":"Adv Drug Deliv Rev"},{"key":"1227_CR41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000434681","volume":"167","author":"L Spina","year":"2015","unstructured":"Spina L, Weisskopf M, von Moos S, Graf N, K\u00fcndig TM, Senti G. Comparison of microneedles and Adhesive-Tape stripping in skin Preparation for epicutaneous allergen delivery. Int Arch Allergy Immunol. 2015;167:103\u20139. https:\/\/doi.org\/10.1159\/000434681.","journal-title":"Int Arch Allergy Immunol"},{"key":"1227_CR42","doi-asserted-by":"publisher","first-page":"120563","DOI":"10.1016\/j.ijpharm.2021.120563","volume":"601","author":"S Hirobe","year":"2021","unstructured":"Hirobe S, Susai R, Takeuchi H, Eguchi R, Ito S, Quan Y-S, et al. Characteristics of immune induction by transcutaneous vaccination using dissolving microneedle patches in mice. Int J Pharm. 2021;601:120563. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120563.","journal-title":"Int J Pharm"},{"key":"1227_CR43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejpb.2022.06.004","volume":"177","author":"Y Yu","year":"2022","unstructured":"Yu Y, Wang H, Guo B, Wang B, Wan Z, Zhang Y, et al. Microneedle-based two-step transdermal delivery of Langerhans cell-targeting immunoliposomes induces a Th1-biased immune response. Eur J Pharm Biopharm. 2022;177:68\u201380. https:\/\/doi.org\/10.1016\/j.ejpb.2022.06.004.","journal-title":"Eur J Pharm Biopharm"},{"key":"1227_CR44","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ejpb.2014.05.003","volume":"88","author":"K van der Maaden","year":"2014","unstructured":"van der Maaden K, Varypataki EM, Romeijn S, Ossendorp F, Jiskoot W, Bouwstra J. Ovalbumin-coated pH-sensitive microneedle arrays effectively induce ovalbumin-specific antibody and T-cell responses in mice. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV. 2014;88:310\u20135. https:\/\/doi.org\/10.1016\/j.ejpb.2014.05.003.","journal-title":"Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV"},{"key":"1227_CR45","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1039\/c9tb00448c","volume":"7","author":"X Wu","year":"2019","unstructured":"Wu X, Li Y, Chen X, Zhou Z, Pang J, Luo X, et al. A surface charge dependent enhanced Th1 antigen-specific immune response in lymph nodes by transfersome-based nanovaccine-loaded dissolving microneedle-assisted transdermal immunization. J Mater Chem B. 2019;7:4854\u201366. https:\/\/doi.org\/10.1039\/c9tb00448c.","journal-title":"J Mater Chem B"},{"key":"1227_CR46","doi-asserted-by":"publisher","unstructured":"Wang Y, Kong Y, Wu MX. Innovative systems to deliver allergen powder for epicutaneous immunotherapy. Front Immunol. 2021;12. https:\/\/doi.org\/10.3389\/fimmu.2021.647954.","DOI":"10.3389\/fimmu.2021.647954"},{"key":"1227_CR47","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2147\/IJN.S20413","volume":"6","author":"A Kumar","year":"2011","unstructured":"Kumar A, Li X, Sandoval MA, Rodriguez BL, Sloat BR, Cui Z. Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin. Int J Nanomed. 2011;6:1253\u201364. https:\/\/doi.org\/10.2147\/IJN.S20413.","journal-title":"Int J Nanomed"},{"key":"1227_CR48","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1248\/bpb.b16-00768","volume":"40","author":"Y Ito","year":"2017","unstructured":"Ito Y, Matsumoto K, Osakama N, Yoshioka R, Kobuchi S, Sakaeda T, et al. Dissolving microneedles as skin allergy test device. Biol Pharm Bull. 2017;40:531\u20134. https:\/\/doi.org\/10.1248\/bpb.b16-00768.","journal-title":"Biol Pharm Bull"},{"key":"1227_CR49","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.2147\/IJN.S132456","volume":"12","author":"J-H Zhao","year":"2017","unstructured":"Zhao J-H, Zhang Q-B, Liu B, Piao X-H, Yan Y-L, Hu X-G, et al. Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant. Int J Nanomed Dove Press. 2017;12:4763\u201372. https:\/\/doi.org\/10.2147\/IJN.S132456.","journal-title":"Int J Nanomed Dove Press"},{"key":"1227_CR50","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1039\/c9tb02061f","volume":"8","author":"Z Li","year":"2020","unstructured":"Li Z, He Y, Deng L, Zhang Z-R, Lin Y. A fast-dissolving microneedle array loaded with Chitosan nanoparticles to evoke systemic immune responses in mice. J Mater Chem B. 2020;8:216\u201325. https:\/\/doi.org\/10.1039\/c9tb02061f.","journal-title":"J Mater Chem B"},{"key":"1227_CR51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijpharm.2013.02.006","volume":"447","author":"L Guo","year":"2013","unstructured":"Guo L, Chen J, Qiu Y, Zhang S, Xu B, Gao Y. Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant. Int J Pharm. 2013;447:22\u201330. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.02.006.","journal-title":"Int J Pharm"},{"key":"1227_CR52","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s11095-021-03070-4","volume":"38","author":"Y-J Choi","year":"2021","unstructured":"Choi Y-J, Kim K-A, Jung J-H, Choi Y-S, Baek S-K, Kim S-T, et al. Epicutaneous allergen administration with microneedles as a novel method of immunotherapy for house dust mite (HDM) allergic rhinitis. Pharm Res. 2021;38:1199\u2013207. https:\/\/doi.org\/10.1007\/s11095-021-03070-4.","journal-title":"Pharm Res"},{"key":"1227_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.08.017","author":"AK Shakya","year":"2018","unstructured":"Shakya AK, Lee CH, Gill HS. Coated microneedle based cutaneous immunotherapy prevents Der p1 induced airway allergy in mice. J Allergy Clin Immunol. 2018;142 :2007\u20132011.e3. https:\/\/doi.org\/10.1016\/j.jaci.2018.08.017."},{"key":"1227_CR54","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jconrel.2017.08.012","volume":"265","author":"AK Shakya","year":"2017","unstructured":"Shakya AK, Lee CH, Gill HS. Cutaneous vaccination with coated microneedles prevents development of airway allergy. J Control Release Off J Control Release Soc. 2017;265:75\u201382. https:\/\/doi.org\/10.1016\/j.jconrel.2017.08.012.","journal-title":"J Control Release Off J Control Release Soc"},{"key":"1227_CR55","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1021\/acs.molpharmaceut.0c00447","volume":"17","author":"AK Shakya","year":"2020","unstructured":"Shakya AK, Lee CH, Gill HS. Microneedle-Mediated Allergen-Specific immunotherapy for the treatment of airway allergy in mice. Mol Pharm Am Chem Soc. 2020;17:3033\u201342. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00447.","journal-title":"Mol Pharm Am Chem Soc"},{"key":"1227_CR56","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/pharmaceutics12030267","volume":"12","author":"S Ito","year":"2020","unstructured":"Ito S, Hirobe S, Kawakita T, Saito M, Quan Y-S, Kamiyama F, et al. Characteristic of K3 (CpG-ODN) as a transcutaneous vaccine formulation adjuvant. Pharmaceutics. 2020;12:267. https:\/\/doi.org\/10.3390\/pharmaceutics12030267.","journal-title":"Pharmaceutics"},{"key":"1227_CR57","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/cea.13688","volume":"50","author":"KH Park","year":"2020","unstructured":"Park KH, Oh EY, Han H, Kim JD, Kim SJ, Jeong KY, et al. Efficacy of transdermal immunotherapy with biodegradable microneedle patches in a murine asthma model. Clin Exp Allergy. 2020;50:1084\u201392. https:\/\/doi.org\/10.1111\/cea.13688.","journal-title":"Clin Exp Allergy"},{"key":"1227_CR58","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jconrel.2024.01.018","volume":"366","author":"J Zhao","year":"2024","unstructured":"Zhao J, He P, Jiang M, He C, Zhao Y, Zhang Z, et al. Transdermally delivered tolerogenic nanoparticles induced effective immune tolerance for asthma treatment. J Controlled Release. 2024;366:637\u201349. https:\/\/doi.org\/10.1016\/j.jconrel.2024.01.018.","journal-title":"J Controlled Release"},{"key":"1227_CR59","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jconrel.2019.03.027","volume":"302","author":"NMD van der Burg","year":"2019","unstructured":"van der Burg NMD, Depelsenaire ACI, Crichton ML, Kuo P, Phipps S, Kendall MAF. A low inflammatory, Langerhans cell-targeted microprojection patch to deliver ovalbumin to the epidermis of mouse skin. J Controlled Release. 2019;302:190\u2013200. https:\/\/doi.org\/10.1016\/j.jconrel.2019.03.027.","journal-title":"J Controlled Release"},{"key":"1227_CR60","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.biomaterials.2017.10.013","volume":"150","author":"JH Kim","year":"2018","unstructured":"Kim JH, Shin JU, Kim SH, Noh JY, Kim HR, Lee J, et al. Successful transdermal allergen delivery and allergen-specific immunotherapy using biodegradable microneedle patches. Biomaterials. 2018;150:38\u201348. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.10.013.","journal-title":"Biomaterials"},{"key":"1227_CR61","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jaci.2021.12.794","volume":"150","author":"M Bandyopadhyay","year":"2022","unstructured":"Bandyopadhyay M, Morelli AE, Balmert SC, Ward NL, Erdos G, Sumpter TL, et al. Skin codelivery of contact sensitizers and neurokinin-1 receptor antagonists integrated in microneedle arrays suppresses allergic contact dermatitis. J Allergy Clin Immunol. 2022;150:114\u201330. https:\/\/doi.org\/10.1016\/j.jaci.2021.12.794.","journal-title":"J Allergy Clin Immunol"},{"key":"1227_CR62","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jconrel.2019.09.022","volume":"314","author":"AK Shakya","year":"2019","unstructured":"Shakya AK, Ingrole RSJ, Joshi G, Uddin MJ, Anvari S, Davis CM, et al. Microneedles coated with peanut allergen enable desensitization of peanut sensitized mice. J Controlled Release. 2019;314:38\u201347. https:\/\/doi.org\/10.1016\/j.jconrel.2019.09.022.","journal-title":"J Controlled Release"},{"key":"1227_CR63","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2217\/imt-2021-0206","volume":"14","author":"JJ Landers","year":"2022","unstructured":"Landers JJ, Janczak KW, Shakya AK, Zarnitsyn V, Patel SR, Baker JR Jr, et al. Targeted allergen-Specific immunotherapy within the skin improves allergen delivery to induce desensitization to peanut. Immunotherapy Taylor Francis. 2022;14:539\u201352. https:\/\/doi.org\/10.2217\/imt-2021-0206.","journal-title":"Immunotherapy Taylor Francis"},{"key":"1227_CR64","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2019.11.022","volume":"145","author":"Y Yu","year":"2020","unstructured":"Yu Y, Kiran Kumar MN, Wu MX. Delivery of allergen powder for safe and effective epicutaneous immunotherapy. J Allergy Clin Immunol. 2020;145:597\u2013609. https:\/\/doi.org\/10.1016\/j.jaci.2019.11.022.","journal-title":"J Allergy Clin Immunol"},{"key":"1227_CR65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11095-019-2728-y","volume":"37","author":"S Ito","year":"2020","unstructured":"Ito S, Hirobe S, Kuwabara Y, Nagao M, Saito M, Quan Y-S, et al. Immunogenicity of milk Protein-Containing hydrophilic gel patch for epicutaneous immunotherapy for milk allergy. Pharm Res. 2020;37:35. https:\/\/doi.org\/10.1007\/s11095-019-2728-y.","journal-title":"Pharm Res"},{"key":"1227_CR66","doi-asserted-by":"publisher","first-page":"103556","DOI":"10.1016\/j.drudis.2023.103556","volume":"28","author":"JL Paris","year":"2023","unstructured":"Paris JL, Vora LK, Torres MJ, Mayorga C, Donnelly RF. Microneedle array patches for allergen-specific immunotherapy. Drug Discov Today. 2023;28:103556. https:\/\/doi.org\/10.1016\/j.drudis.2023.103556.","journal-title":"Drug Discov Today"},{"key":"1227_CR67","doi-asserted-by":"publisher","unstructured":"Hackethal J. Microvascular effects of microneedles with subsequent histamin application in the skin prick test. Skin Res Technol. John Wiley & Sons, Ltd; 2021;27:400\u20133. https:\/\/doi.org\/10.1111\/srt.12969","DOI":"10.1111\/srt.12969"},{"key":"1227_CR68","doi-asserted-by":"publisher","first-page":"e13413","DOI":"10.1111\/srt.13413","volume":"29","author":"KH Lee","year":"2023","unstructured":"Lee KH, Kim JD, Jeong DH, Kim SM, Park CO, Lee KH. Development of a novel microneedle platform for biomarker assessment of atopic dermatitis patients. Skin Res Technol Off J Int Soc Bioeng Skin ISBS Int Soc Digit Imaging Skin ISDIS Int Soc Skin Imaging ISSI. 2023;29:e13413. https:\/\/doi.org\/10.1111\/srt.13413.","journal-title":"Skin Res Technol Off J Int Soc Bioeng Skin ISBS Int Soc Digit Imaging Skin ISDIS Int Soc Skin Imaging ISSI"},{"key":"1227_CR69","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00403-022-02400-9","volume":"315","author":"J-H Song","year":"2023","unstructured":"Song J-H, An EJ, Sung CY, Jeong DH, Lee G, Park S-Y. A comparative study on a biodegradable hyaluronic acid microneedle patch with a needleless patch for dry skin in atopic dermatitis: a single-blinded, split-body, randomized controlled trial. Arch Dermatol Res. 2023;315:569\u201381. https:\/\/doi.org\/10.1007\/s00403-022-02400-9.","journal-title":"Arch Dermatol Res"},{"key":"1227_CR70","doi-asserted-by":"publisher","first-page":"123215","DOI":"10.1016\/j.ijpharm.2023.123215","volume":"643","author":"L Song","year":"2023","unstructured":"Song L, Chi J, Li Z, Tao Y, Sun Y, Zhou Q, et al. An inflammation-responsive double-layer microneedle patch for recurrent atopic dermatitis therapy. Int J Pharm. 2023;643:123215. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123215.","journal-title":"Int J Pharm"},{"key":"1227_CR71","doi-asserted-by":"publisher","first-page":"2302410","DOI":"10.1002\/adma.202302410","volume":"35","author":"C Edwards","year":"2023","unstructured":"Edwards C, Shah SA, Gebhardt T, Jewell CM. Exploiting unique features of microneedles to modulate immunity. Adv Mater. 2023;35:2302410. https:\/\/doi.org\/10.1002\/adma.202302410.","journal-title":"Adv Mater"},{"key":"1227_CR72","doi-asserted-by":"publisher","first-page":"e2001691","DOI":"10.1002\/adhm.202001691","volume":"10","author":"M Jang","year":"2021","unstructured":"Jang M, Kang BM, Yang H, Ohn J, Kwon O, Jung H. High-Dose steroid dissolving microneedle for relieving atopic dermatitis. Adv Healthc Mater. 2021;10:e2001691. https:\/\/doi.org\/10.1002\/adhm.202001691.","journal-title":"Adv Healthc Mater"},{"key":"1227_CR73","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.1039\/d3bm00182b","volume":"11","author":"Y-L Chen","year":"2023","unstructured":"Chen Y-L, Chang C-C, Lin Y-C, Chen M-C. Double-layered PLGA\/HA microneedle systems as a long-acting formulation of polyphenols for effective and long-term management of atopic dermatitis. Biomater Sci. 2023;11:4995\u20135011. https:\/\/doi.org\/10.1039\/d3bm00182b.","journal-title":"Biomater Sci"},{"key":"1227_CR74","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.actbio.2021.05.032","volume":"130","author":"Y-H Chiu","year":"2021","unstructured":"Chiu Y-H, Wu Y-W, Hung J-I, Chen M-C. Epigallocatechin gallate\/L-ascorbic acid-loaded poly-\u03b3-glutamate microneedles with antioxidant, anti-inflammatory, and Immunomodulatory effects for the treatment of atopic dermatitis. Acta Biomater. 2021;130:223\u201333. https:\/\/doi.org\/10.1016\/j.actbio.2021.05.032.","journal-title":"Acta Biomater"},{"key":"1227_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000525451","volume":"30","author":"HM Jang","year":"2023","unstructured":"Jang HM, Kim H, Park S-Y, An EJ, Sung CY, Jeong DH, et al. Dissolvable microneedle patch increases the therapeutic effect of Jawoongo on DNCB-Induced atopic dermatitis in mice. Complement Med Res. 2023;30:1\u201310. https:\/\/doi.org\/10.1159\/000525451.","journal-title":"Complement Med Res"},{"key":"1227_CR76","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/pharmaceutics14020347","volume":"14","author":"R Murty","year":"2022","unstructured":"Murty R, Sankaranarayanan A, Bowland II, Mena-Lapaix J, Prausnitz MR. Angled insertion of microneedles for targeted antigen delivery to the Epidermis. Pharmaceutics. Multidisciplinary Digit Publishing Inst. 2022;14:347. https:\/\/doi.org\/10.3390\/pharmaceutics14020347.","journal-title":"Multidisciplinary Digit Publishing Inst"},{"key":"1227_CR77","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1021\/acs.molpharmaceut.8b00895","volume":"16","author":"AJ Courtenay","year":"2019","unstructured":"Courtenay AJ, Rodgers AM, McCrudden MTC, McCarthy HO, Donnelly RF. Novel Hydrogel-Forming microneedle array for intradermal vaccination in mice using ovalbumin as a model protein antigen. Mol Pharm. 2019;16:118\u201327. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00895.","journal-title":"Mol Pharm"},{"key":"1227_CR78","doi-asserted-by":"publisher","unstructured":"Yao L, Fan Z, Han S, Sun N, Che H. Apigenin attenuates the allergic reactions by competitively binding to ER with estradiol. Front Pharmacol. 2020;11. https:\/\/doi.org\/10.3389\/fphar.2020.01046.","DOI":"10.3389\/fphar.2020.01046"},{"key":"1227_CR79","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1398-9995.2011.02742.x","volume":"67","author":"H Yamashita","year":"2012","unstructured":"Yamashita H, Takahashi K, Tanaka H, Nagai H, Inagaki N. Overcoming food allergy through acquired tolerance conferred by transfer of Tregs in a murine model. Allergy. 2012;67:201\u20139. https:\/\/doi.org\/10.1111\/j.1398-9995.2011.02742.x.","journal-title":"Allergy"},{"key":"1227_CR80","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jinf.2005.07.021","volume":"52","author":"AJ Stewart","year":"2006","unstructured":"Stewart AJ, Devlin PM. The history of the smallpox vaccine. J Infect. 2006;52:329\u201334. https:\/\/doi.org\/10.1016\/j.jinf.2005.07.021.","journal-title":"J Infect"},{"key":"1227_CR81","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/1744666X.2019.1593138","volume":"15","author":"A Langlois","year":"2019","unstructured":"Langlois A, Graham F, B\u00e9gin P. Epicutaneous peanut patch device for the treatment of peanut allergy. Expert Rev Clin Immunol Taylor Francis. 2019;15:449\u201360. https:\/\/doi.org\/10.1080\/1744666X.2019.1593138.","journal-title":"Expert Rev Clin Immunol Taylor Francis"},{"key":"1227_CR82","doi-asserted-by":"publisher","unstructured":"L L, M L, S V, V L, A G-P, A M, et al. Epicutaneous allergen immunotherapy induces a profound and selective modulation in skin dendritic-cell subsets. J Allergy Clin Immunol. 2022;150. https:\/\/doi.org\/10.1016\/j.jaci.2022.05.025.","DOI":"10.1016\/j.jaci.2022.05.025"},{"key":"1227_CR83","doi-asserted-by":"publisher","first-page":"114458","DOI":"10.1016\/j.addr.2022.114458","volume":"190","author":"LD Nesovic","year":"2022","unstructured":"Nesovic LD, Shakya AK, Gill HS. Treating allergies via skin \u2013 Recent advances in cutaneous allergen immunotherapy. Adv Drug Deliv Rev. 2022;190:114458. https:\/\/doi.org\/10.1016\/j.addr.2022.114458.","journal-title":"Adv Drug Deliv Rev"},{"key":"1227_CR84","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jconrel.2016.10.003","volume":"243","author":"P-L Herv\u00e9","year":"2016","unstructured":"Herv\u00e9 P-L, Descamps D, Deloizy C, Dhelft V, Laubreton D, Bouguyon E, et al. Non-invasive epicutaneous vaccine against respiratory syncytial virus: preclinical proof of concept. J Control Release Off J Control Release Soc. 2016;243:146\u201359. https:\/\/doi.org\/10.1016\/j.jconrel.2016.10.003.","journal-title":"J Control Release Off J Control Release Soc"},{"key":"1227_CR85","doi-asserted-by":"publisher","first-page":"1290003","DOI":"10.3389\/falgy.2023.1290003","volume":"4","author":"P-L Herv\u00e9","year":"2023","unstructured":"Herv\u00e9 P-L, Dioszeghy V, Matthews K, Bee KJ, Campbell DE, Sampson HA. Recent advances in epicutaneous immunotherapy and potential applications in food allergy. Front Allergy. 2023;4:1290003. https:\/\/doi.org\/10.3389\/falgy.2023.1290003.","journal-title":"Front Allergy"},{"key":"1227_CR86","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/all.15709","volume":"78","author":"M Bastin","year":"2023","unstructured":"Bastin M, Carr WW, Davis CM, Fleischer DM, Lieberman JA, Mustafa SS, et al. Immune response evolution in peanut epicutaneous immunotherapy for peanut-allergic children. Allergy. 2023;78:2467\u201376. https:\/\/doi.org\/10.1111\/all.15709.","journal-title":"Allergy"},{"key":"1227_CR87","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/1744666X.2024.2315221","volume":"20","author":"C Dupont","year":"2024","unstructured":"Dupont C, Burks AW, Fleischer DM, Bee KJ, Chainani S, Sampson HA. Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergy. Expert Rev Clin Immunol. 2024;20:623\u201333. https:\/\/doi.org\/10.1080\/1744666X.2024.2315221.","journal-title":"Expert Rev Clin Immunol"},{"key":"1227_CR88","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1001\/jamapediatrics.2023.6630","volume":"178","author":"D Petroni","year":"2024","unstructured":"Petroni D, B\u00e9gin P, Bird JA, Brown-Whitehorn T, Chong HJ, Fleischer DM, et al. Varying doses of epicutaneous immunotherapy with viaskin milk vs placebo in children with cow\u2019s milk allergy: A randomized clinical trial. JAMA Pediatr. 2024;178:345\u201353. https:\/\/doi.org\/10.1001\/jamapediatrics.2023.6630.","journal-title":"JAMA Pediatr"},{"key":"1227_CR89","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.cgh.2019.05.014","volume":"18","author":"JM Spergel","year":"2020","unstructured":"Spergel JM, Elci OU, Muir AB, Liacouras CA, Wilkins BJ, Burke D, et al. Efficacy of epicutaneous immunotherapy in children with Milk-Induced eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2020;18:328\u2013e3367. https:\/\/doi.org\/10.1016\/j.cgh.2019.05.014.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1227_CR90","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jaip.2020.08.015","volume":"9","author":"A DunnGalvin","year":"2021","unstructured":"DunnGalvin A, Fleischer DM, Campbell DE, O\u2019B Hourihane J, Green TD, Sampson HA, et al. Improvements in quality of life in children following epicutaneous immunotherapy (EPIT) for peanut allergy in the PEPITES and PEOPLE studies. J Allergy Clin Immunol Pract. 2021;9:216\u2013e2241. https:\/\/doi.org\/10.1016\/j.jaip.2020.08.015.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1227_CR91","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1001\/jama.2017.16591","volume":"318","author":"HA Sampson","year":"2017","unstructured":"Sampson HA, Shreffler WG, Yang WH, Sussman GL, Brown-Whitehorn TF, Nadeau KC, et al. Effect of varying doses of epicutaneous immunotherapy vs placebo on reaction to peanut protein exposure among patients with peanut sensitivity: A randomized clinical trial. JAMA. 2017;318:1798\u2013809. https:\/\/doi.org\/10.1001\/jama.2017.16591.","journal-title":"JAMA"},{"key":"1227_CR92","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.9152","author":"E Harris","year":"2023","unstructured":"Harris E, Trial. Skin patch for peanut allergy effective in toddlers. JAMA. 2023. https:\/\/doi.org\/10.1001\/jama.2023.9152. 329:1907.","journal-title":"JAMA"},{"key":"1227_CR93","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1001\/jama.2019.1113","volume":"321","author":"DM Fleischer","year":"2019","unstructured":"Fleischer DM, Greenhawt M, Sussman G, B\u00e9gin P, Nowak-Wegrzyn A, Petroni D, et al. Effect of epicutaneous immunotherapy vs placebo on reaction to peanut protein ingestion among children with peanut allergy: the PEPITES randomized clinical trial. JAMA. 2019;321:946\u201355. https:\/\/doi.org\/10.1001\/jama.2019.1113.","journal-title":"JAMA"},{"key":"1227_CR94","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jaci.2024.01.001","volume":"153","author":"HS Gill","year":"2024","unstructured":"Gill HS. Microneedle technology for allergen immunotherapy via the skin. J Allergy Clin Immunol. 2024;153:656\u201362. https:\/\/doi.org\/10.1016\/j.jaci.2024.01.001.","journal-title":"J Allergy Clin Immunol"},{"key":"1227_CR95","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.jaci.2016.08.017","volume":"139","author":"SM Jones","year":"2017","unstructured":"Jones SM, Sicherer SH, Burks AW, Leung DYM, Lindblad RW, Dawson P, et al. Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults. J Allergy Clin Immunol. 2017;139:1242\u2013e12529. https:\/\/doi.org\/10.1016\/j.jaci.2016.08.017.","journal-title":"J Allergy Clin Immunol"},{"key":"1227_CR96","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.jaip.2021.11.017","volume":"10","author":"JA Pongracic","year":"2022","unstructured":"Pongracic JA, Gagnon R, Sussman G, Siri D, Oriel RC, Brown-Whitehorn TF, et al. Safety of epicutaneous immunotherapy in Peanut-Allergic children: REALISE randomized clinical trial results. J Allergy Clin Immunol Pract. 2022;10:1864\u2013e187310. https:\/\/doi.org\/10.1016\/j.jaip.2021.11.017.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1227_CR97","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.jaci.2016.01.008","volume":"137","author":"SM Jones","year":"2016","unstructured":"Jones SM, Agbotounou WK, Fleischer DM, Burks AW, Pesek RD, Harris MW, et al. Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the viaskin patch. J Allergy Clin Immunol. 2016;137:1258\u2013e126110. https:\/\/doi.org\/10.1016\/j.jaci.2016.01.008.","journal-title":"J Allergy Clin Immunol"},{"key":"1227_CR98","doi-asserted-by":"publisher","first-page":"124479","DOI":"10.1016\/j.ijpharm.2024.124479","volume":"662","author":"LD Nesovic","year":"2024","unstructured":"Nesovic LD, Gonzalez Cruz PE, Rychener N, Wilks LR, Gill HS. Standardizing the skin tape stripping method for sensitization and using it to create a mouse model of peanut allergy. Int J Pharm. 2024;662:124479. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124479.","journal-title":"Int J Pharm"},{"key":"1227_CR99","doi-asserted-by":"publisher","unstructured":"Cm G, Ja N, Ac W, Bc F. Assessment of the lateral diffusion and penetration of topically applied drugs in humans using a novel concentric tape stripping design. Pharm Res. 2012;29. https:\/\/doi.org\/10.1007\/s11095-012-0731-7.","DOI":"10.1007\/s11095-012-0731-7"},{"key":"1227_CR100","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12967-018-1701-6","volume":"16","author":"S Esposito","year":"2018","unstructured":"Esposito S, Isidori C, Pacitto A, Salvatori C, Sensi L, Frati F, et al. Epicutaneous immunotherapy in rhino-conjunctivitis and food allergies: a review of the literature. J Transl Med. 2018;16:329. https:\/\/doi.org\/10.1186\/s12967-018-1701-6.","journal-title":"J Transl Med"},{"key":"1227_CR101","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.4049\/jimmunol.1003134","volume":"186","author":"V Dioszeghy","year":"2011","unstructured":"Dioszeghy V, Mondoulet L, Dhelft V, Ligouis M, Puteaux E, Benhamou P-H, et al. Epicutaneous immunotherapy results in rapid allergen uptake by dendritic cells through intact skin and downregulates the allergen-specific response in sensitized mice. J Immunol Baltim Md 1950. 2011;186:5629\u201337. https:\/\/doi.org\/10.4049\/jimmunol.1003134.","journal-title":"J Immunol Baltim Md 1950"},{"key":"1227_CR102","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/all.12600","volume":"70","author":"G Senti","year":"2015","unstructured":"Senti G, von Moos S, Tay F, Graf N, Johansen P, K\u00fcndig TM. Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials. Allergy. 2015;70:707\u201310. https:\/\/doi.org\/10.1111\/all.12600.","journal-title":"Allergy"},{"key":"1227_CR103","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1080\/17425247.2019.1649655","volume":"16","author":"C-Y Hsiao","year":"2019","unstructured":"Hsiao C-Y, Yang S-C, Alalaiwe A, Fang J-Y. Laser ablation and topical drug delivery: a review of recent advances. Expert Opin Drug Deliv. 2019;16:937\u201352. https:\/\/doi.org\/10.1080\/17425247.2019.1649655.","journal-title":"Expert Opin Drug Deliv"},{"key":"1227_CR104","doi-asserted-by":"publisher","unstructured":"D S, Lm I. Novel Pathways for Non-invasive Laser-assisted Drug Delivery: A Critical Review. AAPS PharmSciTech. 2025;26. https:\/\/doi.org\/10.1208\/s12249-025-03199-0.","DOI":"10.1208\/s12249-025-03199-0"},{"key":"1227_CR105","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s13555-020-00478-5","volume":"11","author":"T Searle","year":"2021","unstructured":"Searle T, Ali FR, Al-Niaimi F. Lessons learned from the first decade of Laser-Assisted drug delivery. Dermatol Ther. 2021;11:93\u2013104. https:\/\/doi.org\/10.1007\/s13555-020-00478-5.","journal-title":"Dermatol Ther"},{"key":"1227_CR106","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1208\/s12249-024-02849-z","volume":"25","author":"E Haghsay Khashechi","year":"2024","unstructured":"Haghsay Khashechi E, Afaghmehr A, Heidarizade N, Barfar A, Shokri J. Laser-mediated solutions: breaking barriers in transdermal drug delivery. AAPS PharmSciTech. 2024;25:142. https:\/\/doi.org\/10.1208\/s12249-024-02849-z.","journal-title":"AAPS PharmSciTech"},{"key":"1227_CR107","doi-asserted-by":"publisher","unstructured":"Whs N, Sd S. Laser-Assisted drug delivery: A systematic review of safety and adverse events. Pharmaceutics; 2022. p. 14. https:\/\/doi.org\/10.3390\/pharmaceutics14122738.","DOI":"10.3390\/pharmaceutics14122738"},{"key":"1227_CR108","doi-asserted-by":"publisher","unstructured":"Lee SE, Seo J, Lee SH. The Mechanism of Sonophoresis and the Penetration Pathways. In: Dragicevic N, I. Maibach H, editors. Percutaneous Penetration Enhanc; 2017. pp. 15\u201330. https:\/\/doi.org\/10.1007\/978-3-662-53273-7_2","DOI":"10.1007\/978-3-662-53273-7_2"},{"key":"1227_CR109","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijpharm.2008.10.014","volume":"368","author":"A Dahlan","year":"2009","unstructured":"Dahlan A, Alpar HO, Stickings P, Sesardic D, Murdan S. Transcutaneous immunisation assisted by low-frequency ultrasound. Int J Pharm. 2009;368:123\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2008.10.014.","journal-title":"Int J Pharm"},{"key":"1227_CR110","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/s0168-3659(99)00274-6","volume":"66","author":"S Babiuk","year":"2000","unstructured":"Babiuk S, Baca-Estrada M, Babiuk LA, Ewen C, Foldvari M. Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery. J Control Release Off J Control Release Soc. 2000;66:199\u2013214. https:\/\/doi.org\/10.1016\/s0168-3659(99)00274-6.","journal-title":"J Control Release Off J Control Release Soc"},{"key":"1227_CR111","doi-asserted-by":"publisher","first-page":"7749","DOI":"10.2147\/IJN.S174759","volume":"13","author":"BC-Q Seah","year":"2018","unstructured":"Seah BC-Q, Teo BM. Recent advances in ultrasound-based transdermal drug delivery. Int J Nanomed. 2018;13:7749\u201363. https:\/\/doi.org\/10.2147\/IJN.S174759.","journal-title":"Int J Nanomed"},{"key":"1227_CR112","doi-asserted-by":"publisher","unstructured":"Maruani A, Vierron E, Machet L, Giraudeau B, Halimi J-M, Boucaud A. Tolerance of low-frequency ultrasound sonophoresis: a double-blind randomized study on humans. Skin Res Technol Off J Int Soc Bioeng Skin ISBS Int Soc Digit Imaging Skin ISDIS Int Soc Skin Imaging ISSI. 2012;18:151\u20136. https:\/\/doi.org\/10.1111\/j.1600-0846.2011.00546.x.","DOI":"10.1111\/j.1600-0846.2011.00546.x"},{"key":"1227_CR113","doi-asserted-by":"publisher","unstructured":"Yn K, A N, J G, Rh G. Iontophoretic drug delivery. Adv Drug Deliv Rev. 2004;56. https:\/\/doi.org\/10.1016\/j.addr.2003.10.026.","DOI":"10.1016\/j.addr.2003.10.026"},{"key":"1227_CR114","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1080\/10717544.2017.1282555","volume":"24","author":"J Lee","year":"2017","unstructured":"Lee J, Kwon K, Kim M, Min J, Hwang NS, Kim W-S. Transdermal iontophoresis patch with reverse electrodialysis. Drug Deliv. 2017;24:701\u20136. https:\/\/doi.org\/10.1080\/10717544.2017.1282555.","journal-title":"Drug Deliv"},{"key":"1227_CR115","doi-asserted-by":"publisher","unstructured":"Ra H, N A, T H, H A, K K. Use of Iontophoresis Technology for Transdermal Delivery of a Minimal mRNA Vaccine as a Potential Melanoma Therapeutic. Biol Pharm Bull. 2023;46. https:\/\/doi.org\/10.1248\/bpb.b22-00746.","DOI":"10.1248\/bpb.b22-00746"},{"key":"1227_CR116","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3390\/pharmaceutics14030525","volume":"14","author":"M Hasan","year":"2022","unstructured":"Hasan M, Khatun A, Kogure K. Iontophoresis of biological macromolecular Drugs. Pharmaceutics. Multidisciplinary Digit Publishing Inst. 2022;14:525. https:\/\/doi.org\/10.3390\/pharmaceutics14030525.","journal-title":"Multidisciplinary Digit Publishing Inst"},{"key":"1227_CR117","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3349\/ymj.2022.0092","volume":"63","author":"CO Park","year":"2022","unstructured":"Park CO, Kim HL, Park J-W. Microneedle transdermal drug delivery systems for Allergen-Specific Immunotherapy, skin disease Treatment, and vaccine development. Yonsei Med J. 2022;63:881\u201391. https:\/\/doi.org\/10.3349\/ymj.2022.0092.","journal-title":"Yonsei Med J"},{"key":"1227_CR118","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1007\/s13346-023-01298-8","volume":"13","author":"E Zhang","year":"2023","unstructured":"Zhang E, Zeng B, Song R, Yao L, Che H. Sustained antigens delivery using composite microneedles for effective epicutaneous immunotherapy. Drug Deliv Transl Res. 2023;13:1828\u201341. https:\/\/doi.org\/10.1007\/s13346-023-01298-8.","journal-title":"Drug Deliv Transl Res"},{"key":"1227_CR119","doi-asserted-by":"publisher","unstructured":"Y Y, J Y, D W, Ar K, Z G. Polymeric microneedles for transdermal protein delivery. Adv Drug Deliv Rev. 2018;127. https:\/\/doi.org\/10.1016\/j.addr.2018.01.015.","DOI":"10.1016\/j.addr.2018.01.015"},{"key":"1227_CR120","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1021\/acs.molpharmaceut.8b00768","volume":"15","author":"AK Shakya","year":"2018","unstructured":"Shakya AK, Lee CH, Uddin MJ, Gill HS. Assessment of Th1\/Th2 bias of STING agonists coated on microneedles for possible use in skin allergen immunotherapy. Mol Pharm. 2018;15:5437\u201343. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00768.","journal-title":"Mol Pharm"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-025-01227-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-025-01227-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-025-01227-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T05:09:51Z","timestamp":1760764191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-025-01227-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,18]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1227"],"URL":"https:\/\/doi.org\/10.1007\/s11882-025-01227-4","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.jaci.2018.08.017IF:","asserted-by":"subject"}]},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,18]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors declare that there is no conflict of interest, and there are no any interests involved in the publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"46"}}